Iron Availability Influences Aggregation, Biofilm, Adhesion and Invasion of Pseudomonas Aeruginosa and Burkholderia Cenocepacia
Open accessAbstract
Pseudomonas aeruginosa and Burkholderia cenocepacia are predominant opportunistic pathogens in cystic fibrosis (CF) patients. In healthy humans the lower respiratory tract as well as all mucosa, contains a very low free iron concentration (10(-18) M), while in CF patients sputum iron concentration is very high, showing a median value of 63x10(-6) M. Accumulation of catalytic reactive iron heavily contributes to subsequent clinical complications in the lung disorders by the production of reactive oxygen species and increases bacterial growth and virulence. The data reported in this study indicate that low iron concentration (Fe3+ 1 microM)induced free-living forms and motility both in P. aeruginosa and B. cenocepacia, while high iron concentrations (Fe3+ 10 and 100 microM) stimulated aggregation and biofilm formation already in the fluid phases, so demonstrating that aggregation and biofilm formation are positively iron-modulated in these bacteria. Moreover, the different morphological forms (free-living, aggregates and biofilm) showed different capabilities of adhering and invading the bronchial cell line A549. P. aeruginosa PAO1 aggregates, and mostly biofilm, exerted the highest adhesion efficiency, while B. cenocepacia PV1 aggregates or biofilm the lowest. A significant reduction in invasion efficiency by P. aeruginosa biofilm and a significant increase in cell internalization by B. cenocepacia biofilm has been reported. Therefore, the iron availability is an important signal to which P. aeruginosa and B. cenocepacia counteract by leaving the motile free-living forms and entering into a new lifestyle, i.e. biofilm. These data could contribute to explain that the iron-overload of the sputum of CF patients, inducing nonmotile forms, aggregates and biofilm, may facilitate penetration of host epithelial barriers contributing to the establishment of infection, colonization, persistence and systemic spread of these opportunistic pathogens.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In cystic fibrosis patients, high bronchoalveolar iron shifts the balance between apo- and holo-forms of LF towards the latter, compromising the antibiofilm activity of LF.
“This shifts the balance between apoand holo-forms of LF towards the latter, thus compromising the antibiofilm activity of LF (Berlutti et al., 2005;Rogan et al., 2004;Stites et al., 1999).”
From Iron in infection and immunity (2020) · cites this paper as Berlutti et al., 2005
Cites
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,634 · see citing works
Weinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254 · see citing works
Boulos, L., Prévost, M., Barbeau, B., Coallier, J., & Desjardins, R. (1999) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(99)00048-2 · Cited by 1,125 · see citing works
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026 · see citing works
Schaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945 · see citing works
The changing epidemiology of cystic fibrosis
FitzSimmons, S. C. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83478-x · Cited by 935 · see citing works
Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
Isles, A. F., MacLusky, I., Corey, M. L., Gold, R., Prober, C. G., Fleming, P. C., & Levison, H. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80993-2 · Cited by 846 · see citing works
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 693 · see citing works
Huber, B. E., Riedel, K., Hentzer, M., et al. (2001) · Microbiology · doi:10.1099/00221287-147-9-2517 · Cited by 457 · see citing works
Biofilm resistance to antimicrobial agents
Xu, K. D., McFeters, G. A., & Stewart, P. S. (2000) · Microbiology · doi:10.1099/00221287-146-3-547 · Cited by 327 · see citing works
Iron acquisition and its control in pseudomonas aeruginosa many roads lead to rome
Poole, K. (2003) · Frontiers in bioscience · doi:10.2741/1051 · Cited by 248 · see citing works
Burkholderia cenocepacia sp. nov.—a new twist to an old story
Vandamme, P. A. R., Holmes, B., Coenye, T., et al. (2003) · Research in Microbiology · doi:10.1016/s0923-2508(03)00026-3 · Cited by 240 · see citing works
Burkholderia cepacia complex infection in patients with cystic fibrosis
Mahenthiralingam, E., Baldwin, A., & Vandamme, P. A. R. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-7-533 · Cited by 214 · see citing works
Sajjan, U. S., Sun, L., Goldstein, R., et al. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.4.1030-1038.1995 · Cited by 155 · see citing works
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia
Burns, J. L., Jonas, M., Chi, E. Y., et al. (1996) · Infection and Immunity · doi:10.1128/iai.64.10.4054-4059.1996 · Cited by 147 · see citing works
Meluleni, G. J., Grout, M., Evans, D. J., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2029 · Cited by 130 · see citing works
Role of Flagella in Host Cell Invasion by Burkholderia cepacia
Tomich, M., Herfst, C. A., Golden, J. W., & Mohr, C. D. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.1799-1806.2002 · Cited by 122 · see citing works
Iron Deficiency in Cystic Fibrosis
Reid, D. W., Withers, N., Francis, L., Wilson, J. W., & Kotsimbos, T. C. (2002) · CHEST Journal · doi:10.1378/chest.121.1.48 · Cited by 116 · see citing works
Stites, S. W., Walters, B., O'Brien-Ladner, A. R., Bailey, K., & Wesselius, L. (1998) · CHEST Journal · doi:10.1378/chest.114.3.814 · Cited by 95 · see citing works
Siderophore presence in sputa of cystic fibrosis patients
Haas, B., Kraut, J. R., Marks, J., Zanker, S. C., & Castignetti, D. (1991) · Infection and Immunity · doi:10.1128/iai.59.11.3997-4000.1991 · Cited by 89 · see citing works
Schwab, U. E., Leigh, M. W., Ribeiro, C. M. P., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4547-4555.2002 · Cited by 84 · see citing works
Woods, C. W., Bressler, A. M., LiPuma, J. J., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383313 · Cited by 59 · see citing works
Furano, K., & Campagnari, A. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1843-1848.2003 · Cited by 52 · see citing works
Wyckoff, T. J. O., Thomas, B., Hassett, D. J., & Wozniak, D. J. (2002) · Microbiology · doi:10.1099/00221287-148-11-3423 · Cited by 50 · see citing works
Generation of a reproducible nutrient‐depleted biofilm of Escherichia coli and Burkholderia cepacia
Bühler, T., Ballestero, S., Desai, M., et al. (1998) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1998.853501.x · Cited by 35 · see citing works
Tomich, M., & Mohr, C. D. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1009-1020.2004 · Cited by 27 · see citing works
Petrucca, A., Cipriani, P., Valenti, P., et al. (2003) · Research in Microbiology · doi:10.1016/s0923-2508(03)00145-1 · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Lactoferrin a multiple bioactive protein: an overview
García-Montoya, I. A., Cendón, T. S., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.018 · Cited by 473 · see citing works
Lactoferrin: a natural Glycoprotein involved in iron and inflammatory homeostasis
Rosa, L., Cutone, A., Lepanto, M., Paesano, R., & Valenti, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091985 · Cited by 376 · see citing works
Self-citationIron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359 · see citing works
Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition
Wang, Y., Wilks, J. C., Danhorn, T., Ramos, I., Croal, L., & Newman, D. K. (2011) · Journal of Bacteriology · doi:10.1128/jb.00396-11 · Cited by 239 · see citing works
The impact of metal availability on immune function during infection
Monteith, A. J., & Skaar, E. P. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.08.004 · Cited by 83 · see citing works
Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
Tyrrell, J., & Callaghan, M. (2016) · Microbiology · doi:10.1099/mic.0.000220 · Cited by 56 · see citing works
- Authors
- Berlutti, F., Morea, C., Battistoni, A., Sarli, S., Cipriani, P., Superti, F., Ammendolia, M. G., & Valenti, P.
- Affiliations
- Sapienza University of Rome (IT)
- University of Rome Tor Vergata (IT)
- Istituto Superiore di Sanità (IT)
- Department of Experimental Medicine II University of Naples; ITALY
- Corresponding author
- Valenti, P.
- Venue
- International Journal of Immunopathology and Pharmacology
- Publisher
- SAGE Publications
- Published
- 2005-10
- Volume
- 18
- Issue
- 4
- Pages
- 661-670
- ISSN
- 0394-6320 (ISSN-L)
- 2058-7384
- OpenAlex
- W1591767079
- Cited by
- 122
- References
- 27
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 3 · 2023: 11 · 2022: 5 · 2021: 6 · 2020: 12 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 4 · 2012: 9
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- International Journal of Immunopathology and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Epidemiology › Burkholderia infections and melioidosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- iron availability, Pseudomonas aeruginosa, Burkholderia cenocepacia, biofilm formation, bacterial aggregation, bacterial adhesion, host cell invasion, cystic fibrosis, bacterial motility, opportunistic pathogens, A549 cells
- MeSH terms
- Bronchi, Cell Adhesion, Fluorescent Dyes, Humans, Iron, Microscopy, Electron, Scanning, Pseudomonas aeruginosa, Burkholderia cepacia, Biofilms, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review